NASDAQ: ARTV
Artiva Biotherapeutics Inc Stock Ownership - Who owns Artiva Biotherapeutics?

Insider buying vs selling

Have Artiva Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fred AslanCEO2026-09-0823,429$10.92
$255.75kSell
Fred AslanCEO2026-09-0361,888$11.16
$690.36kSell
Christopher HoranCTO2026-09-0310,366$11.16
$115.63kSell
Jennifer BushCOO;CLO2026-09-038,391$11.16
$93.60kSell
Subhashis BanerjeeMed2026-09-031,100$11.16
$12.27kSell
Subhashis BanerjeeMed2026-08-278,222$12.01
$98.74kSell
Subhashis BanerjeeMed2026-08-275,306$1.92
$10.19kBuy
Subhashis BanerjeeMed2026-08-18429$1.92
$823.68Buy
Subhashis BanerjeeMed2026-08-18429$12.00
$5.15kSell
Ra Capital Management LPDirector2026-07-3124,944$9.93
$247.69kBuy

1 of 5

ARTV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARTV insiders and whales buy or sell their stock.

ARTV Shareholders

What type of owners hold Artiva Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gc Corp12.27%5,999,703$50.64MInsider
Yongjun Huh10.06%4,916,249$41.49MInsider
5am Partners VI LLC4.81%2,353,304$19.86MInsider
Venbio Global Strategic Fund III LP3.96%1,936,637$16.35MInsider
Fred Aslan3.28%1,604,765$13.54MInsider
Jennifer Bush0.77%374,529$3.16MInsider
Christopher Horan0.66%323,084$2.73MInsider
Thad Allen Huston0.45%220,000$1.86MInsider
Wellington Biomedical Innovation Master Investors Cayman I LP0.40%194,108$1.64MInsider
Subhashis Banerjee0.35%170,947$1.44MInsider

1 of 3

ARTV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARTV0.08%38.21%Net BuyingNet Buying
CCCC0.10%16.27%Net SellingNet Selling
EDIT0.08%21.44%Net SellingNet Selling
ZURA0.08%58.81%Net Buying
AVIR0.07%28.16%Net Buying

Artiva Biotherapeutics Stock Ownership FAQ

Who owns Artiva Biotherapeutics?

Artiva Biotherapeutics (NASDAQ: ARTV) is owned by 0.08% institutional shareholders, 38.21% Artiva Biotherapeutics insiders, and 61.71% retail investors. Gc Corp is the largest individual Artiva Biotherapeutics shareholder, owning 6.00M shares representing 12.27% of the company. Gc Corp's Artiva Biotherapeutics shares are currently valued at $51.66M.

If you're new to stock investing, here's how to buy Artiva Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.